Author

András Budai

Semmelweis University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Ákos LukátsiD· 1 shared Alexandra Pal-Kajtar· 1 shared András Dénes Marton· 1 shared Attila Szappanos· 1 shared Balázs BeszterceiiD· 1 shared Birgitta Lappeteläinen· 1 shared György Tibor BaloghiD· 1 shared Krisztián A. KovácsiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Ákos LukátsORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Three nitrogen atoms turn old kinase inhibitors into new targetable remedy

Balázs Besztercei, Réka Antal, Leena Tähtivaara, Birgitta Lappeteläinen, Niina Jääskeläinen, Attila Szappanos, Ákos Lukáts, Alexandra Pal-Kajtar, András Budai, András Dénes Marton, Marcell Stifter-Mursits, László Hiripi, György Tibor Balogh, Marc Cerrada‐Gimenez, Krisztián A. Kovács

This paper introduces photoactivatable VEGFR2 inhibitors that enhance retinal disease treatment by light-triggered activation, reducing required doses and systemic exposure.

Journal of Medicinal Chemistry · Oct 4, 2026Peer-reviewedPharmacology & Toxicology